IPSEY News Alert Ipsen S.A. ADR (IPSEY) 12.6335 09/20/2014 2

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ipsen S.A. ADR (IPSEY) 12.6335 $IPSEY

Ipsen Biopharmaceuticals, Inc. Announces Key Medical and Commercial Hires
Business Wire - Wed Sep 10, 8:37AM CDT
Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), today announced key hires as the company continues to build its executive management capabilities. The company has identified bolstering its presence in North America as a key strategic priority, and these additions to the senior leadership team represent an integral move forward in executing Ipsen's continued growth.

Ipsen Announces Acceptance of Filings for Somatuline(R) in the Treatment of GEP-NETs(1) in the US with Priority Review
Business Wire - Mon Sep 01, 9:07AM CDT
Ipsen N.A., an affiliate of Ipsen (Euronext:IPN; ADR:IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review of its supplemental New Drug Application (sNDA) for Somatuline(R) Depot(R) 120mg injection in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The FDA designates priority review status to drug candidates that have the potential to offer a significant improvement in treatment compared to currently approved options. A decision is expected in early Q1, 2015.

Ipsen Announces Acceptance of Filings for Somatuline(R) in the Treatment of GEP-NET(1)s in the US with Priority Review and in Europe
Business Wire - Mon Sep 01, 12:00AM CDT
Regulatory News:

Ipsen: 2014 Half-Year Results and 2014 Objectives
Business Wire - Fri Aug 29, 12:00AM CDT
--Strong Somatuline(R) growth of 14.6%(1), up double-digit across all geographies(2)

Ipsen Announces Second Resupply of Increlex(R) (mecasermin [rDNA origin] Injection) in the U.S. in 2014
Business Wire - Tue Aug 26, 9:07AM CDT
--Ipsen continues to work with the FDA to release future batches of Increlex(R)

Ipsen Appoints Cynthia Schwalm as President and CEO of Ipsen North America
Business Wire - Wed Aug 20, 8:07AM CDT
Ipsen (Euronext:IPN; ADR:IPSEY) today announced that Cynthia Schwalm has been named President and CEO of Ipsen N.A., responsible for all commercial and medical affairs operations throughout the region. She will assume oversight of all areas supporting the North American Business and will report to Pierre Boulud, EVP of Specialty Care Commercial Operations.

New England Journal of Medicine publishes Ipsen's Somatuline(R) CLARINET(R) Phase III results in patients with metastatic gastroenteropancreatic neuroendocrine tumors
Business Wire - Thu Jul 17, 12:00AM CDT
--After 96 weeks of investigational treatment with Somatuline(R), the risk of disease progression or death was reduced by 53%

New England Journal of Medicine Publishes Ipsen's Somatuline(R) CLARINET(R) Phase III Results in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors
Business Wire - Wed Jul 16, 4:29PM CDT
--After 96 weeks of investigational treatment with Somatuline(R), the risk of disease progression or death was reduced by 53%

Ipsen and Galderma become exclusive partners for development and marketing of neurotoxins in the US, Canada, Brazil and Europe(1)
Business Wire - Fri Jul 11, 12:00AM CDT
--Ipsen and Galderma to collaborate on development and commercialization of new neurotoxins, including their respective liquid formulations

Ipsen submits marketing authorization applications in the U.S. and Europe for Somatuline(R) (lanreotide) in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
Business Wire - Tue Jul 01, 7:30AM CDT
--Marketing authorization variations submitted in 25 countries of the European Union

Ipsen's net profit up by 6.4% in H1 2013
M2 - Fri Aug 30, 7:59AM CDT
Ipsen SA (Euronext: IPN) (Paris: IPN.PA), a specialty-driven pharmaceutical company, on Friday reported consolidated net profit attributable to shareholders of EUR96.2m, or diluted EPS of EUR1.15, for the first half 2013, ended 30 June 2013.

Baxter closes deal for potential hemophilia drug
By The Associated Press - AP - Thu Mar 21, 8:39AM CDT
Baxter International Inc. has closed its acquisition of a potential hemophilia treatment from the French drugmaker Ipsen and Inspiration Biopharmaceuticals Inc. in a deal that could be worth more than $180 million.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Red Cat Stock Drama: Revenue Targets and Legal Waves

Updated Category News Views 143

Red Cat's Revenue Predictions Crash and Burn Sitting there on August 6, 2026, Red Cat Holdings had everyone believing they were on a fast track to hitting a hefty revenue target: $150–$180 million for FY2026. CEO Jeffrey Thompson didn't mince words, boasting confidence like a captain before a storm. Fast forward three months, and they're waving the white flag, tossing...

Continue Reading
Unilumin's APEC 2026 Showcase Is a Useful Field Test

Updated Category News Views 41

Few sales pitches get stress-tested by a thousand journalists, a major airport, and a leaders' summit all at once. That is the useful part of Unilumin's role as an official sponsor of APEC 2026 in Shenzhen. The company says its LED systems were installed across summit venues, the media center, transportation hubs, and city landmarks as the 33rd APEC Economic Leaders'...

Continue Reading
Philadelphia Firm Targets 100 Toys for Children This Holiday

Updated Category News Views 157

A hundred unopened toys can look modest on paper, yet that is exactly why this Philadelphia effort lands differently than the usual chest-thumping corporate charity chatter. van der Veen, Hartshorn & Levin has set a clear holiday target: collect 100 new, unwrapped toys for children in the Philadelphia area through the U.S. Marine Corps Reserve Toys for Tots program. No...

Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 196

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious

Updated Category News Views 95

Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...

Continue Reading
Hanmi Compressor Tests Vietnam Before Wider Expansion

Updated Category News Views 29

Compressed air is the sort of factory necessity nobody brags about until it fails, and that is precisely why Hanmi Compressor’s Vietnam plan deserves a sober look. The Daegu-based specialist is not arriving with a grand export victory lap. It is still building the front door: a website, a promotional video, and a process for finding Vietnamese manufacturers and...

Continue Reading
TIER IV Simplifies Autonomous Driving with CARLA 1.0

Updated Category News Views 63

No More Detours in Autonomous Development Ever messed with a puzzle that just won't fit until suddenly, it clicks? That's what TIER IV just pulled off with their latest work on CARLA 1.0, the open-source simulator. There's no more mucking about with that separate Python-based bridge to get things communicating—now we're talking native Autoware support. A direct line to...

Continue Reading
Abacus Global Faces Scrutiny Over Accounting Practices

Updated Category News Views 208

Storm Clouds Gather over Abacus Global Management If it ain't one thing, it's another—at least that's what folks holding the bag with Abacus Global (ABX) are thinking right now. News of a pending investigation has dropped like a lead balloon, and the air is thick with scrutiny over their financial dealings. We're jawing about related-party transactions now under the...

Continue Reading
Visa Direct Tests Stablecoin Prefunding in Asia-Pacific

Updated Category News Views 149

Cross-border payouts have always had an ugly little problem: money can move digitally in theory, then sit around waiting for banks to wake up in practice. Triple-A’s new collaboration with Visa Direct aims straight at that nuisance in Asia-Pacific, allowing eligible clients to use stablecoins to prefund cross-border payouts while the recipient still gets local currency....

Continue Reading
Dolby's Strong Quarter Meets a Flat 2027 Reality Check

Updated Category News Views 81

A licensing machine just coughed up a very good quarter, then told investors not to expect the engine to accelerate next year. That is the whole Dolby story in one uncomfortable breath. NYSE:DLB finished fiscal 2026 with fourth-quarter revenue of $374 million, up from $307 million a year earlier, while GAAP diluted earnings climbed to $0.86 from $0.51. Those are not...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring ASML: Should You Invest or Hold Off?

Updated Category News Views 112

Analyzing ASML's Impressive Market Performance Recently, ASML stock has demonstrated significant growth, with the share price increasing dramatically in a short period. From a previous value of $1,028, it now stands at approximately $1,422.92, resulting in an impressive rise of 41% for investors who have held their shares. ASML has established itself as a critical player...

Continue Reading
374Water Moves Towards Strategic Stock Split for Growth

Updated Category News Views 299

Overview of the Special Meeting of Stockholders 374Water Inc., a key player in the organic waste destruction sector, has announced a significant step aimed at enhancing shareholder value. The company has filed a preliminary proxy statement for a Special Meeting of Stockholders, where they will seek approval for a reverse stock split between a ratio of 1 for 8 and 1 for...

Continue Reading
BlocScale Hits Soft Cap with 13,000 XRP: What You Need to Know

Updated Category News Views 150

BlocScale Achieves Soft Cap with 13,000 XRP The XRP ecosystem has reached a significant milestone as BlocScale, the inaugural native launchpad on the XRP Ledger, successfully raised 13,000 XRP during its token sale. This achievement is a testament to the growing support from investors across the crypto landscape, showcasing BlocScale's potential as a leader in...

Continue Reading
Vanguard's Investor Choice: A Transformative Shift in Voting

Updated Category News Views 412

Vanguard's Investor Choice Shows Dramatic Growth Vanguard has recently unveiled exciting insights from its Investor Choice pilot program, indicating a significant surge in investor engagement during the proxy voting season. This initiative has more than doubled participation, showcasing an impressive commitment from individual investors eager to have a say in critical...

Continue Reading
UST Celebrates Leadership Excellence with 2024 Achievements

Updated Category News Views 247

UST, a heavyweight in digital transformation solutions, racked up nine accolades at the Brandon Hall Group Human Capital Management (HCM) Excellence Awards back in 2024. They snagged four Golds among them, positioning themselves as leaders in human capital strategies. Traders watching this space couldn’t help but wonder: Is UST’s approach to workplace culture and...

Continue Reading